KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $121.2 million.

  • Incyte's Cost of Revenue rose 3694.41% to $121.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $372.1 million, marking a year-over-year increase of 1924.64%. This contributed to the annual value of $372.1 million for FY2025, which is 1924.64% up from last year.
  • Incyte's Cost of Revenue amounted to $121.2 million in Q4 2025, which was up 3694.41% from $99.0 million recorded in Q3 2025.
  • In the past 5 years, Incyte's Cost of Revenue ranged from a high of $121.2 million in Q4 2025 and a low of $29.2 million during Q1 2021
  • Its 5-year average for Cost of Revenue is $64.9 million, with a median of $60.5 million in 2023.
  • In the last 5 years, Incyte's Cost of Revenue surged by 4583.85% in 2022 and then soared by 278.21% in 2025.
  • Over the past 5 years, Incyte's Cost of Revenue (Quarter) stood at $43.9 million in 2021, then surged by 34.85% to $59.2 million in 2022, then increased by 17.9% to $69.8 million in 2023, then increased by 26.86% to $88.5 million in 2024, then surged by 36.94% to $121.2 million in 2025.
  • Its Cost of Revenue stands at $121.2 million for Q4 2025, versus $99.0 million for Q3 2025 and $78.8 million for Q2 2025.